The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global organ preservation market reached a value of US$ 149.1 Million in 2020. Looking forward, IMARC Group expects the market to reach a value of US$ 218 Million by 2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Organ preservation refers to the process of preserving healthy organs harvested from the body of donors. The process involves the removal of organs from the donor’s body, storing it for transportation and then transplanting it into the receiver’s body without significant damage. It utilizes various techniques, such as hypothermic machine perfusion, static cold storage (SCS) and normothermic machine perfusion (NMP), to maintain the temperature and oxygen levels of kidneys, liver, lung, heart and other organs. The preservation techniques and solutions used are essential for donor organ quality, which directly influences the morbidity and survival rates of a patient after transplantation.
The increasing prevalence of chronic diseases, along with the growing geriatric population across the globe, are among the key factors driving the growth of the market. Owing to the frequent occurrences of organ failures due to diabetes, cardiovascular disorders (CVDs), obesity, and other such severe medical conditions, there is an increasing need for organ preservation procedures. The advent of innovative and advanced techniques, such as NMP, for organ preservation, is acting as a growth-inducing factor. Such techniques aid in decreasing the probability of reperfusion injury during transplantation and exhibits improved results in cold storage for clinical and experimental studies. Moreover, an increasing number of government and non-government policies and initiatives to promote organ donation are impacting the market growth positively. The rising number of individuals volunteering to donate their organs for transplantation and research purposes are also driving the market further. Other factors, including enhanced research and development (R&D) and significant advancements in the organ preservation infrastructure, are also projected to contribute to the market growth significantly.
IMARC Group provides an analysis of the key trends in each sub-segment of the global organ preservation market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on preservation solution, organ donation type, technique, organ type and end-user.
Breakup by Preservation Solution:
Breakup by Organ Donation Type:
Breakup by Technique:
Breakup by Organ Type:
Breakup by End-User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being 21st Century Medicine, Biolife Solutions, Bridge to Life Ltd., Bristol-Myers Squibb, Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals., Lifeline Scientific, OrganOx, Paragonix Technologies, TransMedics, Waters Medical Systems, Xvivo Perfusion, etc.
|Base Year of the Analysis||2020|
|Segment Coverage||Preservation Solution, Organ Donation Type, Technique, Organ Type, End-User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||21st Century Medicine, Biolife Solutions, Bridge to Life Ltd., Bristol-Myers Squibb, Dr. Franz Köhler Chemie GmbH, Essential Pharmaceuticals., Lifeline Scientific, OrganOx, Paragonix Technologies, TransMedics, Waters Medical Systems and Xvivo Perfusion|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at